STXBP1 and epilepsy: As an example, Zhu et al. (2020) sought to functionally validate epilepsy-related mutations and generated a strain in which a null mutation was introduced into the C. elegans ortholog of STXBP1, unc-18, via CRISPR/Cas9, which resulted in paralysis.